LiveActive security incident?Get immediate response
CVE Record

CVE-2021-33885: An Insufficient Verification of Data Authenticity vulnerability in B.

An Insufficient Verification of Data Authenticity vulnerability in B. Braun SpaceCom2 prior to 012U000062 allows a remote unauthenticated attacker to send the device malicious data that will be used in place of the correct data. This results in full system command access and execution because of the lack of cryptographic signatures on critical data sets.

CriticalCVSS 10Not KEV-listedUpdated
Glexia's TakeAutomated analysiscritical

Security readout for executives and security teams

Plain-English summary

CVE-2021-33885 is a critical flaw in B. Braun SpaceCom2 where the device can trust malicious data because critical datasets lack cryptographic signatures. A remote unauthenticated attacker could gain full system command execution. For healthcare operators, this is urgent because affected devices may sit in clinical environments where integrity and availability matter.

Executive priority

Treat as high-priority clinical technology risk. The CVSS 10.0 rating and unauthenticated remote command execution impact justify urgent inventory, vendor-guided remediation, and network containment, even though the provided sources do not show active exploitation.

Technical view

The issue is insufficient verification of data authenticity in B. Braun SpaceCom2 before 012U000062. The CVE states malicious remote data can replace correct data, leading to full system command access and execution. CVSS v3.1 is 10.0 with network access, low complexity, no privileges, no user interaction, and high confidentiality, integrity, and availability impact.

Likely exposure

Exposure is limited to environments running B. Braun SpaceCom2 versions before 012U000062. The source bundle does not provide CPEs, deployment counts, or internet exposure data. Healthcare and clinical technology networks using these infusion pump communication components should prioritize asset confirmation.

Exploitation context

The source bundle marks CISA KEV as false and provides no cited evidence of active exploitation. Public research from McAfee disclosed vulnerabilities in globally used B. Braun infusion pump technology, but this prompt does not include exploit-in-the-wild claims.

Researcher notes

Key evidence gaps: the CVE source lists affected vendor/product fields as n/a, provides no CWE, and includes limited remediation detail beyond the version threshold. Avoid broad product assumptions; validate actual SpaceCom2 versions and deployment context directly with the organization and vendor guidance.

Mitigation direction

  • Identify all B. Braun SpaceCom2 deployments and record current firmware or software versions.
  • Update SpaceCom2 systems to 012U000062 or later per B. Braun guidance.
  • Restrict network access to SpaceCom2 management and device communication paths.
  • Monitor vendor advisories for device-specific remediation and clinical safety guidance.
  • Coordinate changes with biomedical engineering and clinical operations teams.

Validation and detection

  • Confirm no SpaceCom2 instance is running a version before 012U000062.
  • Review network segmentation for unauthorized access paths to affected devices.
  • Check asset inventories for unmanaged or undocumented B. Braun SpaceCom2 systems.
  • Verify remediation evidence with maintenance records or vendor management tooling.
  • Document any exceptions with compensating controls and owner approval.
Prepared
Confidence
medium
Sources
4

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

cve · low confidence lookup

CVE-2021-33885 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup
Vulnerability profileCVE Program record
Severity
Critical
CVSS
10 (3.1)
Known Exploited
No
Published

Vector: CVSS:3.1/AC:L/AV:N/A:N/C:H/I:H/PR:N/S:C/UI:N

Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

1CVSS vectors
0Timeline events
0ADP providers
3Source links

CVSS vector scores

1 official score

We collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.

ScoreVersionSeverityVectorExploitImpactSource
10CVSS 3.1CriticalCVSS:3.1/AC:L/AV:N/A:N/C:H/I:H/PR:N/S:C/UI:N3.95.8Primary CVE score

Vulnerability scoring details

Base CVSS 3.1 score

10Critical
CVSS 3.1 vector shape for CVE-2021-33885Attack VectorAttack ComplexityPrivileges RequiredUser InteractionScopeConfidentiality ImpactIntegrity ImpactAvailability Impact

Vector: CVSS:3.1/AC:L/AV:N/A:N/C:H/I:H/PR:N/S:C/UI:N

Attack Vector
NetworkAdjacentLocalPhysical
Attack Complexity
LowHigh
Privileges Required
NoneLowHigh
User Interaction
NoneRequired
Scope
ChangedUnchanged
Confidentiality Impact
HighLowNone
Integrity Impact
HighLowNone
Availability Impact
HighLowNone
Affected products

Products and packages named in the record

VendorProductVersion / packageStatus
n/an/an/aListed
Weakness

CWE details

No CWE listed

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.